Lab Result Communication Tool for Chronic Kidney Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve how lab results are shared with older adults who have chronic kidney disease (CKD). It tests a new tool, the Chronic Kidney Disease (CKD) Lab Result Communication Tool, which personalizes lab results to help patients better understand their CKD risk. Participants will review different versions of lab result reports to determine which is easiest to understand and most useful. Those aged 65 and older, with a UCLA primary care provider and no severe kidney disease, might find this trial a good fit. As an unphased trial, this study offers participants the chance to contribute to research that could enhance the communication of lab results for older adults with CKD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on testing a communication tool rather than medication changes.
What prior data suggests that this lab result communication tool is safe for use in chronic kidney disease patients?
Research has shown that tools like the Lab Result Communication Tool are generally safe. As a digital interface, not a medication or physical treatment, it has no reports of physical harm. By using information from electronic health records, it helps people better understand their health. Designed to provide personalized health information, it poses no direct risks. Past studies with similar tools have shown no safety concerns, indicating it is well-tolerated by users.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to communicate lab results for Chronic Kidney Disease (CKD). Traditional methods often just present raw numbers, which can be confusing. This study is testing different ways of presenting lab results that could really change how patients understand and react to their CKD status. By comparing new user interface designs that either focus on comparing results with others or predicting future health outcomes, they aim to see which method helps patients better understand their condition and motivates them to take action. This could lead to more effective patient engagement and improved health outcomes.
What evidence suggests that this lab result communication tool is effective for chronic kidney disease?
Research has shown that tools like the CKD Lab Result Communication Tool, which participants in this trial will use, help patients better understand their kidney health. One study found that patients' knowledge about chronic kidney disease (CKD) improved from 40% to over 51% after using a similar tool. In this trial, different arms will test various versions of the tool, such as those emphasizing personal risk levels and comparisons to others with similar conditions. Other studies have noted improvements in how patients manage their CKD and communicate with their doctors. These findings suggest the tool could help patients understand and manage their kidney health more effectively.12678
Are You a Good Fit for This Trial?
This trial is for adults aged 65 or older who have chronic kidney disease. It's designed to help them and their healthcare providers better understand lab results using a new personalized tool that calculates individual risk.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
User Experience Testing
Participants engage in a single-visit interaction to test the usability and design of a new lab result communication tool, including live semi-structured interviews and feedback surveys.
Follow-up
Participants are monitored for their emotional response and understanding of the lab results through structured surveys.
What Are the Treatments Tested in This Trial?
Interventions
- Chronic Kidney Disease (CKD) Lab Result Communication Tool
Trial Overview
The study tests a Chronic Kidney Disease Lab Result Communication Tool against the standard report. It aims to see if personalized reports improve understanding of lab results among patients and providers through interviews and surveys.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
Participants in this arm will first be shown a new user interface template report for communication Chronic Kidney Disease (CKD) lab results. This version emphasizes functional interpretation of kidney health and likelihood of progression over the next two years. They will answer a series of questions assessing understanding, emotional response, and likelihood of behavior change based on this presentation. Their responses will be locked in. Immediately afterward, participants will be shown the control version and asked to re-evaluate their responses with reference to their earlier answers.
Participants in this arm will first be shown a new user interface template report for communication CKD lab results. This version emphasizes comparative normalization by presenting personalized CKD risk in relation to results commonly observed among similar adults of comparable age and clinical characteristics. They will answer a series of questions assessing understanding, emotional response, and likelihood of behavior change based on this presentation. Their responses will be locked in. Immediately afterward, participants will be shown the control version and asked to re-evaluate their responses with reference to their earlier answers.
Participants in this arm will first be shown a new user interface template report for communication CKD lab results. This version integrates both outcome expectancy and comparative normalization by presenting personalized CKD risk alongside functional interpretation of kidney health and contextual comparison of similar adults. They will answer a series of questions assessing understanding, emotional response, and likelihood of behavior change based on this presentation. Their responses will be locked in. Immediately afterward, participants will be shown the control version and asked to re-evaluate their responses with reference to their earlier answers.
Participants in this arm will only be shown control version, the standard communication CKD lab results. They will answer a series of questions assessing understanding, emotional response, and likelihood of behavior change based on this presentation.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Johns Hopkins University
Collaborator
Citations
Patient-centered Precision Medicine Lab Result ...
Participants in this arm will first be shown a new user interface template report for communication CKD lab results.
Lab Result Communication Tool for Chronic Kidney Disease
What is the purpose of this trial? This trial tests a new tool designed to communicate lab results more clearly for older adults with chronic kidney disease.
The Kidney Score Platform for Patient and Clinician ...
Outcomes will include changes in patient self-efficacy for chronic kidney disease management (primary outcome), quality of communication ...
Optimizing the use of patients' individual outcome information
We aimed to systematically develop a Chronic Kidney Disease (CKD) dashboard designed to support consultations, test its usability and explore conditions for ...
a qualitative systematic review of barriers, enablers, and ...
This systematic review investigates the barriers, enablers and mechanisms affecting ePROMs implementation in CKD (chronic kidney disease) ...
Patient-Reported Safety Events in Chronic Kidney Disease ...
Background: Monitoring patient-reported outcomes (PROs) may improve safety of chronic kidney disease (CKD) patients.
Patient Electronic Health Record Portal Use and ...
We examined whether patient use of an electronic health record portal was associated with demographics or kidney function and whether portal use predicted ...
Impact of the Kidney Score Platform on Communication ...
Objective We aimed to examine the impact of the Kidney Score Platform (a patient-facing, risk-based online tool that provides interactive ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.